Literature DB >> 10029196

Glutamate receptors in the cingulate cortex, hippocampus, and cerebellar vermis of alcoholics.

G Freund1, K J Anderson.   

Abstract

This study tests the hypothesis that glutamate receptors are altered in the brains of alcoholics as a result of chronic alcohol neurotoxicity. Excessive release of the excitatory neurotransmitter glutamate may damage postsynaptic neurons by increasing calcium flux through N-methyl-D-aspartate (NMDA) receptor-gated ion channels. Alcohol has opposite effects on the NMDA receptor, depending on the duration of exposure. Acute exposure to alcohol inhibits ion flow through NMDA receptors, whereas chronic exposure upregulates the number of these receptors and thereby increases ion flow. Acute withdrawal from alcohol results in hyperexcitability and seizures in the presence of upregulated NMDA receptors, making postsynaptic neurons vulnerable to excitotoxic damage. For this study, 13 grossly and histologically normal brains from alcoholics and 13 brains from nonalcoholic controls were selected from our brain bank. The two groups were matched for age, postmortem interval, and storage time. Maximal binding and affinities of NMDA receptors were determined by quantitative autoradiography in the cingulate cortex, the cornu Ammonis of the hippocampus, and in the cerebellar vermis. Binding was determined with an agonist, L-[3H]glutamate, with a competitive antagonist, [3H]CGP-39653, and with an antagonist binding in the channel interior, [3H]MK-801. No significant differences were found in receptor densities or affinities between alcoholics and controls. Real differences were not likely to be obscured by nonalcohol-related variables because the groups were closely matched for age, autopsy delay, time in storage, and central nervous system medications. Various diseases causing acute and chronic hypoxia did not significantly affect receptor density or affinity. Liver diseases and thiamine deficiency were excluded. A long-lasting upregulation of the number or affinity of NMDA receptors is not a key feature of chronic alcoholics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029196

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

Review 1.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

2.  Astroglia in the Vulnerability and Maintenance of Alcohol Use Disorders.

Authors:  José Javier Miguel-Hidalgo
Journal:  Adv Neurobiol       Date:  2021

Review 3.  Alcoholism and alternative splicing of candidate genes.

Authors:  Toshikazu Sasabe; Shoichi Ishiura
Journal:  Int J Environ Res Public Health       Date:  2010-03-30       Impact factor: 3.390

4.  Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics.

Authors:  Beata Karolewicz; Laurel Johnson; Katalin Szebeni; Craig A Stockmeier; Gregory A Ordway
Journal:  J Psychiatr Res       Date:  2007-05-03       Impact factor: 4.791

5.  The effects of chronic ethanol administration on amygdala neuronal firing and ethanol withdrawal seizures.

Authors:  Hua-Jun Feng; Carl L Faingold
Journal:  Neuropharmacology       Date:  2008-06-03       Impact factor: 5.250

Review 6.  Habitual alcohol seeking: modeling the transition from casual drinking to addiction.

Authors:  Jacqueline M Barker; Jane R Taylor
Journal:  Neurosci Biobehav Rev       Date:  2014-09-02       Impact factor: 8.989

Review 7.  Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders.

Authors:  José J Miguel-Hidalgo
Journal:  Front Mol Neurosci       Date:  2018-03-20       Impact factor: 5.639

8.  Effect of chronic ethanol consumption in rhesus macaques on the nucleus accumbens core transcriptome.

Authors:  Nicole Walter; Rita Cervera-Juanes; Christina Zheng; Priscila Darakjian; Denesa Lockwood; Verginia Cuzon-Carlson; Karina Ray; Suzanne Fei; Don Conrad; Robert Searles; Kathleen Grant; Robert Hitzemann
Journal:  Addict Biol       Date:  2021-05-04       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.